A recent study published in the JAMA Network Open, conducted by the Centers for Disease Control and Prevention (CDC), has examined the effects of the COVID-19 pandemic on hospital-onset antimicrobial-resistant infections. Antimicrobial resistance was found to be on the decline from 2012 till 2019. However, a sudden surge was observed during the acute COVID-19 pandemic…
Infections, primarily those resulting from multi-drug resistant bacteria, are a leading cause of increased morbidity and mortality among patients with cirrhosis. It is essential to understand that the COVID-19 pandemic has potentially influenced the infection patterns in these patients due to various restrictive measures in place globally. The following study aims to highlight and compare…